Robert Piana, MD
Cardiovascular Disease · Nashville, TNNPI 1629068556
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,750 of the $16,349 with a category attached, or 71.9%. Abbott accounts for 71.9% of it on its own, with 6 other manufacturers making up the rest.
Across 51 payments — averaging $320.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$12K
- Edwards Lifesciences$3K
- Abiomed$565
- Teleflex LLC$425
- Boston Scientific$281
- Medtronic$169
- plus $161 from 1 others
Across 34 payments — averaging $1991.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$67K
- Abbott$250
What the payments were for
- Consulting fees$11,75072%
- Travel & lodging$1,75411%
- Food & beverage$2,84517%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $11,762 |
| Edwards Lifesciences | 19 | $2,986 |
| Abiomed | 5 | $565 |
| Teleflex LLC | 4 | $425 |
| Boston Scientific | 2 | $281 |
| Medtronic | 2 | $169 |
| Siemens Medical Solutions USA, Inc. | 1 | $161 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience cornary stent systems$7,100
- CARDIOMEMS$3,900
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,916
- Neuromodulation Dspsbls and Accs$750
- Impella$557
- THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM$433
- Biograph Horizon-3R$161
- GUIDELINER$144
- AVVIGO Guidance System$141
- TRAPLINER$130
- TURNPIKE$128
- FFRangio$112
How this compares
$16,349 in reported general payments places this provider in the 85th percentile of 429 cardiovascular disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $128,480 |
| Repatha SureclickEvolocumab | 121 | $107,177 |
| EntrestoSacubitril/Valsartan | 47 | $72,245 |
| XareltoRivaroxaban | 36 | $38,297 |
| JardianceEmpagliflozin | 16 | $23,575 |
| Ranolazine ErRanolazine | 22 | $2,173 |
| Atorvastatin Calcium | 193 | $1,720 |
| Metoprolol Succinate | 102 | $1,151 |
| ClopidogrelClopidogrel Bisulfate | 93 | $955 |
| Potassium Chloride | 37 | $917 |
| Rosuvastatin Calcium | 86 | $835 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 51 | $772 |
| Ezetimibe | 42 | $698 |
| Prasugrel Hcl | 17 | $664 |
| Amlodipine Besylate | 77 | $645 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Nashville
- Christopher EllisNashville$527K
- Joann LindenfeldNashville$270K
- Andrew ZurickNashville$231K
- Mark ZenkerNashville$225K
- George CrossleyNashville$197K
- Joel PharesNashville$171K
- Arvindh KanagasundramNashville$161K
- Jessica HustonNashville$109K
- Joshua BeckmanNashville$106K
- Travis RichardsonNashville$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.